4.7 Review

Updates in the management of high-grade glioma

期刊

JOURNAL OF NEUROLOGY
卷 261, 期 4, 页码 651-654

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-013-7032-x

关键词

Glioblastoma; Oligodendroglioma; Bevacizumab; Temozolomide; PCV

向作者/读者索取更多资源

The management of high-grade glioma (HGG) has evolved significantly over the last decade. Patients are managed in a multidisciplinary team setting in order to ensure their care is guided by the most current evidenced based treatments. The outcome in patients with HGG, while still poor, has improved in terms of both survival and quality of life during illness. This review discusses a number of developments seen in the management of HGG over the last 5 years.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据